DC4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dexcom Inc

Watchlist Manager

Watchlist

Price: 62.8 EUR 2.28% Market Closed

Market Cap: €24.5B

	Dexcom Inc XETRA:DC4	US
	Sinoma Science & Technology Co Ltd SZSE:002080	CN
E	Experian PLC F:J2B	IE
P	Puma SE F:PUM	DE

Profitability Summary

Dexcom Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

63%

Strong 3Y Average Gross Margin

62%

Declining Gross Margin

64% > 63%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

17%

Operating Margin is Increasing

14% > 21%

Healthy Net Margin

19%

Sustainable 3Y Average Net Margin

15%

Net Margin is Increasing

11% > 19%

Exceptional Free Cash Flow Margin

30%

Strong 3Y Average Free Cash Flow Margin

17%

Free Cash Flow Margin is Increasing

15% > 30%

Exceptional ROE

36%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

17%

ROIC is Increasing

12% > 21%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.